Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:PG

Procter & Gamble (PG)

150.33
-0.05 (0.03%)
as of Jun 18, 2026, 11:39:10 pm Market Open.
135 watching
0
BUY
It reported organic growth up 6% while market share and relative sales growth impressed in today's report. It faces $2.8 billion in commodity freight and currency headwinds, but can pass those costs onto consumers. Shares rallied $5 today.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 25/21, Up 14.1%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with PG has achieved its $152 objective. To remain disciplined, we recommend covering half the position at this time. We recommend keeping the stop at $139.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 25/21, Up 11.1%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with PG is progressing well. We now recommend trailing up the stop (from $100) to $139.
BUY
PG vs. UL Canadians can't ignore the Chinese and Indian markets. They do have political risk, but they will be delivering meaningful prosperity, so ignore that at your peril. PG had a very tough time after the global financial crisis. Still a great company and continues to do well, has outperformed UL. UL is going through changes, and these could lead to outperformance over PG. If you want safe and steady bond proxies, these are the types of companies you want to be thinking about.
BUY
They report Tuesday. Shares have been rallying since reporting organic growth that their peers lack. That said, he prefers JNJ.
DON'T BUY

PG vs. JNJ JNJ valuation of 16-17x earnings is cheaper than PG. JNJ has 3 areas: medical devices, healthcare, pharma. PG is just consumer products, trading at 23x earnings. More opportunity in JNJ, with a caveat on the talc lawsuits. JNJ's medical device side should do well post-Covid. Dividends similar in the 2.5% range.

PARTIAL BUY
A solid buy that you buy over time, a piece at a time, and reinvest the dividends.
DON'T BUY
They report Tuesday. They face tough comps vs. the stay-at-home numbers, and too much competition to pass higher costs to consumers.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly PG is a global leader in consumer staples with brands recognized in over 180 countries. Recent earnings showed a 200% increase in EPS and is expected to grow over 9% over the next five years -- a real steady Eddy. It pays a nice dividend, backed by a 57% payout ratio. We would buy this with a stop loss at $100, looking to achieve $152 -- upside potential over 14%. Yield 2.38% (Analysts’ price target is $151.44)
COMMENT
Reports Wednesday. For once, their numbers will be boosted by a strong US dollar, not pressured by a weak one. They move a ton of merchandise overseas.
BUY
There's a bull market in hygiene, given Covid. The PG CFO expects such clean habits to continue after the pandemic--hygiene won't go away. Consumer habits die hard.
HOLD
This sector has held up reasonably well during this downturn along with utilities. She would continue to hold it and likes the dividend it pays.
COMMENT

He owns Unilever for their global exposure. P&G beat earnings but their revenues were down. It's trading like a growth stock even though it isn't. They have been coming out with new products. There is progress in grooming products but their baby care has been struggling. He also doesn't like their compliance and ethics. They reward 10% of their float to their executives and not helping employees. They are also make polluting products like Pampers and Swiffers.

SELL
The stock, but also the PE has taken off after doing nothing for years. Good observation of the PE as well as stock price. PG are getting rid of their shaving business, which is a debacle with a huge write-down. Exit this, because what you expected to happen to this stock has already happened.
Showing 31 to 45 of 208 entries